JP2000319238A - Chromogen for oxidizable color-developing reagent, determination method using the chromogen and determination reagent - Google Patents
Chromogen for oxidizable color-developing reagent, determination method using the chromogen and determination reagentInfo
- Publication number
- JP2000319238A JP2000319238A JP11161473A JP16147399A JP2000319238A JP 2000319238 A JP2000319238 A JP 2000319238A JP 11161473 A JP11161473 A JP 11161473A JP 16147399 A JP16147399 A JP 16147399A JP 2000319238 A JP2000319238 A JP 2000319238A
- Authority
- JP
- Japan
- Prior art keywords
- reagent
- measurement
- measuring
- chromogen
- uric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 220
- 238000000034 method Methods 0.000 title claims description 24
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 14
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 5
- 239000000126 substance Substances 0.000 claims description 45
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical group CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 claims description 26
- 150000003839 salts Chemical class 0.000 claims description 26
- 239000007800 oxidant agent Substances 0.000 claims description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 abstract description 30
- 150000001875 compounds Chemical class 0.000 abstract description 25
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 21
- 102000001554 Hemoglobins Human genes 0.000 abstract description 12
- 108010054147 Hemoglobins Proteins 0.000 abstract description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract description 12
- 235000010323 ascorbic acid Nutrition 0.000 abstract description 10
- 239000011668 ascorbic acid Substances 0.000 abstract description 10
- 229960005070 ascorbic acid Drugs 0.000 abstract description 10
- HRTTZDJOYAFHGI-UHFFFAOYSA-N 3-(n-ethyl-3-methoxyanilino)propanoic acid Chemical compound OC(=O)CCN(CC)C1=CC=CC(OC)=C1 HRTTZDJOYAFHGI-UHFFFAOYSA-N 0.000 abstract description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract description 4
- 238000011161 development Methods 0.000 abstract description 4
- 239000007864 aqueous solution Substances 0.000 abstract description 3
- 150000008044 alkali metal hydroxides Chemical class 0.000 abstract description 2
- 125000005843 halogen group Chemical group 0.000 abstract description 2
- 239000000243 solution Substances 0.000 abstract description 2
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 239000000049 pigment Substances 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- 238000005259 measurement Methods 0.000 description 91
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 79
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 79
- 229940116269 uric acid Drugs 0.000 description 79
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 62
- 239000000523 sample Substances 0.000 description 45
- 235000012000 cholesterol Nutrition 0.000 description 31
- 238000002360 preparation method Methods 0.000 description 30
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 24
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 238000002835 absorbance Methods 0.000 description 16
- 239000013068 control sample Substances 0.000 description 11
- 102000003992 Peroxidases Human genes 0.000 description 10
- -1 carboxyethyl group Chemical group 0.000 description 10
- 108040007629 peroxidase activity proteins Proteins 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 150000001448 anilines Chemical class 0.000 description 9
- 239000012472 biological sample Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 150000001540 azides Chemical class 0.000 description 6
- 238000012790 confirmation Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 description 5
- 238000004040 coloring Methods 0.000 description 5
- 230000001590 oxidative effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 238000000691 measurement method Methods 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- QZTKDVCDBIDYMD-UHFFFAOYSA-N 2,2'-[(2-amino-2-oxoethyl)imino]diacetic acid Chemical compound NC(=O)CN(CC(O)=O)CC(O)=O QZTKDVCDBIDYMD-UHFFFAOYSA-N 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 3
- UVKSMKOQDVSNBN-UHFFFAOYSA-N 3-(3,5-dimethoxyanilino)-2-hydroxypropane-1-sulfonic acid;sodium Chemical compound [Na].COC1=CC(NCC(O)CS(O)(=O)=O)=CC(OC)=C1 UVKSMKOQDVSNBN-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000007995 HEPES buffer Substances 0.000 description 3
- 239000007993 MOPS buffer Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 description 3
- 102000004316 Oxidoreductases Human genes 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 108010092464 Urate Oxidase Proteins 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000006482 condensation reaction Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000005562 fading Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- PHOLIFLKGONSGY-CSKARUKUSA-N (e)-(3-methyl-1,3-benzothiazol-2-ylidene)hydrazine Chemical compound C1=CC=C2S\C(=N\N)N(C)C2=C1 PHOLIFLKGONSGY-CSKARUKUSA-N 0.000 description 2
- BTIDJAQNJLWPTI-UHFFFAOYSA-N 3-(n-ethyl-3,5-dimethoxyanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC(OC)=CC(OC)=C1 BTIDJAQNJLWPTI-UHFFFAOYSA-N 0.000 description 2
- KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical class NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 description 2
- 239000007988 ADA buffer Substances 0.000 description 2
- 108010024957 Ascorbate Oxidase Proteins 0.000 description 2
- 108010089254 Cholesterol oxidase Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 150000004292 cyclic ethers Chemical class 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 2
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 2
- 229910052808 lithium carbonate Inorganic materials 0.000 description 2
- AFQXCZCRJSGHPB-UHFFFAOYSA-N n-ethyl-3-methoxyaniline Chemical compound CCNC1=CC=CC(OC)=C1 AFQXCZCRJSGHPB-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- MWFOPMKUGZLPQA-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methoxyanilino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CCCN(CC)C1=CC=CC(OC)=C1 MWFOPMKUGZLPQA-UHFFFAOYSA-M 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
- AJTVSSFTXWNIRG-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanesulfonic acid Chemical compound OCC[NH+](CCO)CCS([O-])(=O)=O AJTVSSFTXWNIRG-UHFFFAOYSA-N 0.000 description 1
- WNRGWPVJGDABME-UHFFFAOYSA-N 3,5-Dimethoxyaniline Chemical compound COC1=CC(N)=CC(OC)=C1 WNRGWPVJGDABME-UHFFFAOYSA-N 0.000 description 1
- MENXRDLDYNLDHE-UHFFFAOYSA-N 3-(3,5-dimethoxyanilino)propane-1-sulfonic acid Chemical compound COC1=CC(NCCCS(O)(=O)=O)=CC(OC)=C1 MENXRDLDYNLDHE-UHFFFAOYSA-N 0.000 description 1
- UYJCRTFNDLCUIN-UHFFFAOYSA-N 3-(4-fluoro-3,5-dimethoxyanilino)propane-1-sulfonic acid Chemical compound COC1=CC(NCCCS(O)(=O)=O)=CC(OC)=C1F UYJCRTFNDLCUIN-UHFFFAOYSA-N 0.000 description 1
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 1
- NZAVBNVWEPQSBL-UHFFFAOYSA-N 3-(n-ethyl-3,5-dimethoxyanilino)propane-1-sulfonic acid Chemical compound OS(=O)(=O)CCCN(CC)C1=CC(OC)=CC(OC)=C1 NZAVBNVWEPQSBL-UHFFFAOYSA-N 0.000 description 1
- YKTGWJDAQVYXHG-UHFFFAOYSA-N 3-(n-ethyl-3,5-dimethoxyanilino)propanoic acid Chemical compound OC(=O)CCN(CC)C1=CC(OC)=CC(OC)=C1 YKTGWJDAQVYXHG-UHFFFAOYSA-N 0.000 description 1
- CDGBQMHYFARRCC-UHFFFAOYSA-N 3-(n-ethyl-3,5-dimethylanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC(C)=CC(C)=C1 CDGBQMHYFARRCC-UHFFFAOYSA-N 0.000 description 1
- DHOHNBDXAQUXGS-UHFFFAOYSA-N 3-(n-ethyl-4-fluoro-3,5-dimethoxyanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC(OC)=C(F)C(OC)=C1 DHOHNBDXAQUXGS-UHFFFAOYSA-N 0.000 description 1
- NUFBIAUZAMHTSP-UHFFFAOYSA-N 3-(n-morpholino)-2-hydroxypropanesulfonic acid Chemical compound OS(=O)(=O)CC(O)CN1CCOCC1 NUFBIAUZAMHTSP-UHFFFAOYSA-N 0.000 description 1
- RZQXOGQSPBYUKH-UHFFFAOYSA-N 3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound OCC(CO)(CO)NCC(O)CS(O)(=O)=O RZQXOGQSPBYUKH-UHFFFAOYSA-N 0.000 description 1
- XCBLFURAFHFFJF-UHFFFAOYSA-N 3-[bis(2-hydroxyethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound OCCN(CCO)CC(O)CS(O)(=O)=O XCBLFURAFHFFJF-UHFFFAOYSA-N 0.000 description 1
- 239000007991 ACES buffer Substances 0.000 description 1
- 108700016232 Arg(2)-Sar(4)- dermorphin (1-4) Proteins 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 239000007989 BIS-Tris Propane buffer Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102100032566 Carbonic anhydrase-related protein 10 Human genes 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010008488 Glycylglycine Proteins 0.000 description 1
- OWXMKDGYPWMGEB-UHFFFAOYSA-N HEPPS Chemical compound OCCN1CCN(CCCS(O)(=O)=O)CC1 OWXMKDGYPWMGEB-UHFFFAOYSA-N 0.000 description 1
- 239000007996 HEPPS buffer Substances 0.000 description 1
- GIZQLVPDAOBAFN-UHFFFAOYSA-N HEPPSO Chemical compound OCCN1CCN(CC(O)CS(O)(=O)=O)CC1 GIZQLVPDAOBAFN-UHFFFAOYSA-N 0.000 description 1
- 101000867836 Homo sapiens Carbonic anhydrase-related protein 10 Proteins 0.000 description 1
- DBXNUXBLKRLWFA-UHFFFAOYSA-N N-(2-acetamido)-2-aminoethanesulfonic acid Chemical compound NC(=O)CNCCS(O)(=O)=O DBXNUXBLKRLWFA-UHFFFAOYSA-N 0.000 description 1
- 239000007990 PIPES buffer Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 108010055297 Sterol Esterase Proteins 0.000 description 1
- 102000000019 Sterol Esterase Human genes 0.000 description 1
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 1
- 239000007997 Tricine buffer Substances 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 208000034953 Twin anemia-polycythemia sequence Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- HHKZCCWKTZRCCL-UHFFFAOYSA-N bis-tris propane Chemical compound OCC(CO)(CO)NCCCNC(CO)(CO)CO HHKZCCWKTZRCCL-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- 238000001585 disappearance potential spectroscopy Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229940043257 glycylglycine Drugs 0.000 description 1
- JUINSXZKUKVTMD-UHFFFAOYSA-N hydrogen azide Chemical compound N=[N+]=[N-] JUINSXZKUKVTMD-UHFFFAOYSA-N 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- NCBZRJODKRCREW-UHFFFAOYSA-N m-anisidine Chemical compound COC1=CC=CC(N)=C1 NCBZRJODKRCREW-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- NSBIQPJIWUJBBX-UHFFFAOYSA-N n-methoxyaniline Chemical compound CONC1=CC=CC=C1 NSBIQPJIWUJBBX-UHFFFAOYSA-N 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- SVLRFMQGKVFRTB-UHFFFAOYSA-M sodium;3-(3,5-dimethoxyanilino)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].COC1=CC(NCC(O)CS([O-])(=O)=O)=CC(OC)=C1 SVLRFMQGKVFRTB-UHFFFAOYSA-M 0.000 description 1
- IRQRBVOQGUPTLG-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methylanilino)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC=CC(C)=C1 IRQRBVOQGUPTLG-UHFFFAOYSA-M 0.000 description 1
- ZPCAZHPYLUKSMY-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methylanilino)-2-hydroxypropane-1-sulfonate;dihydrate Chemical compound O.O.[Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC=CC(C)=C1 ZPCAZHPYLUKSMY-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- OIWCYIUQAVBPGV-DAQGAKHBSA-N {1-O-hexadecanoyl-2-O-[(Z)-octadec-9-enoyl]-sn-glycero-3-phospho}serine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC OIWCYIUQAVBPGV-DAQGAKHBSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/62—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving uric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、新規な3−アルコ
キシアニリン誘導体又はその塩、及びこれを色原体とし
て用いる、酸化性物質又はペルオキシダーゼ様物質の測
定方法及び測定試薬に関する。本発明は、特に、化学、
生命科学、及び臨床検査等の分野において有用なもので
ある。TECHNICAL FIELD The present invention relates to a novel 3-alkoxyaniline derivative or a salt thereof, and a method and a reagent for measuring an oxidizing substance or a peroxidase-like substance using the same as a chromogen. The invention is particularly directed to chemistry,
It is useful in fields such as life science and clinical testing.
【0002】[0002]
【従来の技術】血液、尿などの生体試料中に含まれる生
体成分を測定することは、疾病の診断において大変有用
なものであり、臨床検査においては酵素学的測定法が普
及し、様々な測定方法が開発されている。このような方
法としては、例えば、酸化酵素を用いて、生体成分から
直接又は間接的に酸化性物質である過酸化水素を生成さ
せ、これをペルオキシダーゼ及び被酸化性発色試薬と混
合、接触させて発色系に導き、酸化縮合反応により被酸
化性発色試薬から生成した色素を光学的に測定すること
により生成した過酸化水素の測定を行い、これにより生
体試料中に含まれる生体成分を測定する方法を挙げるこ
とができる。例えば、尿酸、ブドウ糖、及びコレステロ
ール等の測定に、それぞれウリカーゼ、グルコースオキ
シダーゼ、及びコレステロールオキシダーゼ等の酸化酵
素を働かせて過酸化水素を生成させ、この生成した過酸
化水素をペルオキシダーゼ及び被酸化性発色試薬と混
合、接触させて発色系に導き、酸化縮合反応により被酸
化性発色試薬から生成した色素を光学的に測定すること
により測定し、これより各生体成分を正確に測定するこ
とができる。2. Description of the Related Art Measuring biological components contained in biological samples such as blood and urine is very useful in diagnosing diseases, and enzymatic measurement methods have become widespread in clinical tests. Measurement methods have been developed. As such a method, for example, using an oxidizing enzyme, hydrogen peroxide which is an oxidizing substance is directly or indirectly generated from a biological component, and mixed with and contacted with peroxidase and an oxidizable coloring reagent. A method for measuring the amount of hydrogen peroxide generated by optically measuring a dye generated from an oxidizable color-forming reagent by an oxidative condensation reaction, which leads to a color forming system, and thereby measuring a biological component contained in a biological sample. Can be mentioned. For example, in measuring uric acid, glucose, and cholesterol, etc., uricase, glucose oxidase, and oxidizing enzymes such as cholesterol oxidase act to generate hydrogen peroxide, and the generated hydrogen peroxide is used as a peroxidase and an oxidizable color reagent. , And the mixture is brought into contact with a chromogenic system, and is measured by optically measuring a dye generated from an oxidizable color forming reagent by an oxidative condensation reaction, whereby each biological component can be accurately measured.
【0003】従来、この方法に用いられる被酸化性発色
試薬としては、主に4−アミノアンチピリン等のカップ
ラーと、その縮合対象物として、フェノール又はその誘
導体、あるいはアニリン誘導体等の色原体とを組み合わ
せたものが用いられてきた。しかしながら、これらの被
酸化性発色試薬は、発色後の退色が大きいため呈色の安
定性が悪く、生体試料中のビリルビンやヘモグロビン、
アスコルビン酸等の共存物質の影響を受け、測定誤差を
生じやすいこと、感度が小さく微量成分の測定に不十分
なこと等の欠点を有しているため、より優れた色原体が
求められていた。Conventionally, oxidizable color-forming reagents used in this method mainly include a coupler such as 4-aminoantipyrine and a chromogen such as phenol or a derivative thereof or an aniline derivative as a condensation target. Combinations have been used. However, these oxidizable color-forming reagents are poor in coloration stability due to large fading after color development, and include bilirubin and hemoglobin in biological samples.
Due to the influence of coexisting substances such as ascorbic acid, there are disadvantages such as easy measurement error, low sensitivity and insufficient measurement of trace components.Therefore, a better chromogen is required. Was.
【0004】そこで、特公昭57−27106号公報、
特公昭58−9094号公報、及び特公平2−1519
8号公報にはこれらの問題点を解決すべく、種々のアニ
リン誘導体が色原体として提案されている。しかしなが
ら、これらのアニリン誘導体を色原体に用いた被酸化性
発色試薬は、生成する色素の水溶性は良好であり発色感
度は高いものの、生成する色素の退色が大きいため呈色
の安定性が不十分であったり、生体試料中のビリルビン
やヘモグロビン、アスコルビン酸等の共存物質の影響を
受けやすく、正確な測定をするには必ずしも満足のゆく
ものではない。Therefore, Japanese Patent Publication No. 57-27106,
JP-B-58-9094 and JP-B-2-1519
No. 8 proposes various aniline derivatives as chromogens to solve these problems. However, oxidizable color reagents using these aniline derivatives as chromogens have good water-solubility of the generated dye and high color-forming sensitivity, but have high color fading due to large fading of the generated dye. It is insufficient or easily affected by coexisting substances such as bilirubin, hemoglobin, and ascorbic acid in a biological sample, and is not always satisfactory for accurate measurement.
【0005】また、特開平4−202164号公報や特
開平5−262716号公報にはアニリン誘導体にフル
オロ基を導入したp−フルオロアニリン誘導体が色原体
として提案されている。しかしながら、p−フルオロア
ニリン誘導体の合成は一般的でなく非常に煩雑でありし
かも高価につくことが難点である。[0005] Japanese Patent Application Laid-Open Nos. 4-202164 and 5-262716 propose a p-fluoroaniline derivative in which a fluoro group is introduced into an aniline derivative as a chromogen. However, the synthesis of p-fluoroaniline derivatives is not common and is very complicated, and it is difficult to produce them at a high cost.
【0006】更に、最近、これらの色原体を使用する被
酸化性発色試薬を用いて、生体試料を測定する場合に、
他の試薬に防腐剤として含有させたアジ化ナトリウムが
アジ化水素として気化し、その近傍の色原体を含有する
被酸化性発色試薬に溶け込み、目的とする生体成分が存
在しないにもかかわらず、色原体であるN−(2−ヒド
ロキシ−3−スルホプロピル)−3,5−ジメトキシア
ニリンナトリウム(略名:HDAOS)、N−スルホプ
ロピル−3,5−ジメトキシアニリン(略名:HDAP
S)、N−エチル−N−(2−ヒドロキシ−3−スルホ
プロピル)−3,5−ジメトキシアニリン(略名:DA
OS)、N−エチル−N−スルホプロピル−3,5−ジ
メトキシアニリン(略名:DAPS)、N−エチル−N
−(2−ヒドロキシ−3−スルホプロピル)−3,5−
ジメトキシ−4−フルオロアニリン、N−エチル−N−
スルホプロピル−3,5−ジメトキシ−4−フルオロア
ニリン、又はN−(2−カルボキシエチル)−N−エチ
ル−3,5−ジメトキシアニリン(略名:CEDB)等
の電子供与基を有するアニリン誘導体を発色させてしま
い、測定に用いることが出来なくなることが知られてい
る。Further, recently, when a biological sample is measured using an oxidizable color reagent using these chromogens,
Sodium azide contained in other reagents as a preservative vaporizes as hydrogen azide and dissolves in the oxidizable color-forming reagent containing the chromogen in the vicinity, and despite the absence of the desired biological component Chromogenic N- (2-hydroxy-3-sulfopropyl) -3,5-dimethoxyaniline sodium (abbreviation: HDAOS), N-sulfopropyl-3,5-dimethoxyaniline (abbreviation: HDAP)
S), N-ethyl-N- (2-hydroxy-3-sulfopropyl) -3,5-dimethoxyaniline (abbreviation: DA
OS), N-ethyl-N-sulfopropyl-3,5-dimethoxyaniline (abbreviation: DAPS), N-ethyl-N
-(2-hydroxy-3-sulfopropyl) -3,5-
Dimethoxy-4-fluoroaniline, N-ethyl-N-
An aniline derivative having an electron donating group such as sulfopropyl-3,5-dimethoxy-4-fluoroaniline or N- (2-carboxyethyl) -N-ethyl-3,5-dimethoxyaniline (abbreviation: CEDB) is used. It is known that the color is developed and cannot be used for measurement.
【0007】また、自動分析装置においては、アジ化物
等の試薬に含まれる成分が自動分析装置等の試薬プロー
ブ(試薬採取ノズル)に付着することにより、この試薬
プローブが次の試薬を採取した際に、試薬プローブに付
着したアジ化物等がその試薬に混入し、色原体である前
記等の電子供与基を有するアニリン誘導体を発色させて
しまい、測定に用いることが出来なくなることが知られ
ている。In an automatic analyzer, a component contained in a reagent such as an azide adheres to a reagent probe (reagent collection nozzle) of the automatic analyzer or the like, so that the reagent probe collects the next reagent. It is known that an azide or the like attached to a reagent probe is mixed into the reagent and causes the aniline derivative having an electron donating group such as the chromogen described above to develop a color, which cannot be used for measurement. I have.
【0008】[0008]
【発明が解決しようとする課題】本発明は、前記の従来
技術における問題点に鑑み、生成する色素の呈色の安定
性が十分であり、かつ生体試料中のビリルビン、ヘモグ
ロビン、及びアスコルビン酸等の共存物質により生じる
測定値への誤差の発生を抑制でき、更にアジ化物等の近
傍の試薬に含まれる成分が試薬に溶け込むことによる試
薬の劣化、及び機能の低下を防ぐことができる被酸化性
発色試薬用色原体、及びこれを用いる測定方法並びに測
定試薬の提供を目的とする。DISCLOSURE OF THE INVENTION In view of the above-mentioned problems in the prior art, the present invention has sufficient coloring stability of the dye to be produced, and has a bilirubin, hemoglobin, ascorbic acid, and the like in a biological sample. Oxidation that can suppress the occurrence of errors in measured values caused by coexisting substances, and also prevent reagent degradation and function degradation due to the dissolution of components contained in nearby reagents such as azide into the reagents It is an object of the present invention to provide a chromogen for a coloring reagent, a measuring method using the same, and a measuring reagent.
【0009】[0009]
【課題を解決するための手段】本発明者らは、前記目的
を達成するために、鋭意検討を行った結果、下記の化学
式(1)で表わされる3−アルコキシアニリン誘導体又
はその塩を色原体として使用し、カップラーと組み合わ
せて用いた場合、生成する色素の呈色は極めて安定で、
かつ生体試料中にビリルビン、ヘモグロビン、及びアス
コルビン酸等の共存物質が含まれることにより生じる測
定値への誤差の発生を抑制することができ、更にアジ化
物等の近傍の試薬に含まれる成分が試薬に溶け込むこと
による試薬の劣化及び機能の低下を防ぐことができ、酸
化性物質又はペルオキシダーゼ様物質を正確に測定する
ことができることを確認して、本発明を完成するに至っ
た。Means for Solving the Problems The present inventors have conducted intensive studies in order to achieve the above object, and as a result, have found that a 3-alkoxyaniline derivative represented by the following chemical formula (1) or a salt thereof can be used as a chromogen. When used as a body and used in combination with a coupler, the coloration of the resulting dye is extremely stable,
In addition, it is possible to suppress the occurrence of errors in measured values caused by coexisting substances such as bilirubin, hemoglobin, and ascorbic acid in a biological sample. The present invention has been completed by confirming that it is possible to prevent the deterioration of the reagent and the decrease in the function due to the dissolution into the reagent and to accurately measure the oxidizing substance or the peroxidase-like substance.
【0010】従って、本発明は、下記の化学式(1)Accordingly, the present invention provides the following chemical formula (1)
【化2】 (式中、R1は炭素数1〜3のアルコキシ基を示し、R
2は水素原子、又は炭素数1〜3のアルキル基を示し、
R3はカルボキシル基で置換された炭素数1〜3のアル
キル基を示す。)で示される、3−アルコキシアニリン
誘導体又はその塩である。Embedded image (Wherein, R 1 represents an alkoxy group having 1 to 3 carbon atoms;
2 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms,
R 3 represents an alkyl group having 1 to 3 carbon atoms substituted with a carboxyl group. ), Or a 3-alkoxyaniline derivative or a salt thereof.
【0011】また、本発明は、前記の3−アルコキシア
ニリン誘導体又はその塩よりなる色原体及びカップラー
を被酸化性発色試薬として用いることを特徴とする酸化
性物質の測定方法である。Further, the present invention is a method for measuring an oxidizing substance, wherein the chromogen and the coupler comprising the above-mentioned 3-alkoxyaniline derivative or a salt thereof are used as an oxidizable color-forming reagent.
【0012】更に、本発明は、前記の3−アルコキシア
ニリン誘導体又はその塩よりなる色原体及びカップラー
を被酸化性発色試薬として用いることを特徴とするペル
オキシダーゼ様物質の測定方法である。また、本発明の
測定方法においては、カップラーが4−アミノアンチピ
リンであることが好適である。Further, the present invention is a method for measuring a peroxidase-like substance, wherein the chromogen and coupler comprising the above-mentioned 3-alkoxyaniline derivative or a salt thereof are used as an oxidizable color-forming reagent. In the measurement method of the present invention, it is preferable that the coupler is 4-aminoantipyrine.
【0013】また、本発明は、前記の3−アルコキシア
ニリン誘導体又はその塩よりなる色原体及びカップラー
を被酸化性発色試薬として含有することを特徴とする酸
化性物質の測定試薬である。Further, the present invention is a reagent for measuring an oxidizing substance, which comprises the chromogen and the coupler comprising the 3-alkoxyaniline derivative or a salt thereof as an oxidizable color-forming reagent.
【0014】更に、本発明は、前記の3−アルコキシア
ニリン誘導体又はその塩よりなる色原体及びカップラー
を被酸化性発色試薬として含有することを特徴とするペ
ルオキシダーゼ様物質の測定試薬である。Further, the present invention is a reagent for measuring a peroxidase-like substance, comprising the chromogen and the coupler comprising the 3-alkoxyaniline derivative or a salt thereof as an oxidizable color-forming reagent.
【0015】また、本発明の測定試薬においては、カッ
プラーが4−アミノアンチピリンであることが好適であ
る。In the measuring reagent of the present invention, the coupler is preferably 4-aminoantipyrine.
【0016】[0016]
【発明の実施の形態】本発明において、化学式(1)で
示される3−アルコキシアニリン誘導体又はその塩にお
いて、R1としては、例えば、メトキシ基、エトキシ
基、プロポキシ基等の炭素数1〜3のアルコキシ基が挙
げられる。ここで、このアルコキシ基は、直鎖でも分枝
鎖の何れでもよい。R2としては、水素原子、又は例え
ば、メチル基、エチル基、プロピル基等の炭素数1〜3
のアルキル基が挙げられる。ここで、このアルキル基
は、直鎖でも分枝鎖の何れでもよい。R3としては、例
えば、カルボキシメチル基、カルボキシエチル基、カル
ボキシプロピル基等の炭素数1〜3のカルボキシル基で
置換されたアルキル基が挙げられる。ここで、炭素数1
〜3のカルボキシル基で置換されたアルキル基は、直鎖
でも分枝鎖の何れでもよく、カルボキシル基の置換位置
も特に限定されない。BEST MODE FOR CARRYING OUT THE INVENTION In the present invention, in a 3-alkoxyaniline derivative represented by the chemical formula (1) or a salt thereof, R 1 is, for example, a C 1 to C 3 -carbon atom such as a methoxy group, an ethoxy group, and a propoxy group. And an alkoxy group of Here, this alkoxy group may be either straight-chain or branched. R 2 is a hydrogen atom or a group having 1 to 3 carbon atoms such as a methyl group, an ethyl group, and a propyl group.
Alkyl group. Here, this alkyl group may be either straight-chain or branched. Examples of R 3 include an alkyl group substituted with a carboxyl group having 1 to 3 carbon atoms such as a carboxymethyl group, a carboxyethyl group, and a carboxypropyl group. Here, carbon number 1
The alkyl group substituted with carboxyl groups of Nos. 1 to 3 may be either linear or branched, and the position of substitution of the carboxyl group is not particularly limited.
【0017】より具体的には、R1としてはOCH3、
OC2H5又はOC3H7が挙げられ、R2としては
H、CH3、CH2CH3、CH2CH2CH3又はC
H(CH3)2が挙げられ、R3としてはCH2COO
H、CH2CH2COOH、CH2CH2CH2COO
H、CH(CH3)CH2COOH又はCH2CH(C
H3)COOHが挙げられる。More specifically, R 1 is OCH 3 ,
OC 2 H 5 or OC 3 H 7, and examples of R 2 is H, CH 3, CH 2 CH 3, CH 2 CH 2 CH 3 or C
H (CH 3 ) 2 and R 3 is CH 2 COO
H, CH 2 CH 2 COOH, CH 2 CH 2 CH 2 COO
H, CH (CH 3 ) CH 2 COOH or CH 2 CH (C
H 3 ) COOH.
【0018】また、化学式(1)で示される3−アルコ
キシアニリン誘導体の塩としては、例えば、ナトリウム
塩、カリウム塩、若しくはカルシウム塩等の金属塩、ア
ンモニウム塩、又はトリエチルアミン塩等を挙げること
ができる。Examples of the salt of the 3-alkoxyaniline derivative represented by the chemical formula (1) include a metal salt such as a sodium salt, a potassium salt, and a calcium salt, an ammonium salt, and a triethylamine salt. .
【0019】本発明における、化学式(1)で示される
3−アルコキシアニリン誘導体は、例えば、以下のよう
にして合成することができる。すなわち、化学式(2)
(式中、R1は前記に同じ。)で示される化合物1モル
に対して1〜3モルの化学式(3)(式中、Xはハロゲ
ン原子を示す。R2は前記に同じ。)で示される化合物
を、メタノール、エタノール、又はイソプロパノールな
どのアルコール類、又は1,4−ジオキサン、テトラヒ
ドロフラン(THF)などの環状エーテル類等の溶媒中
で、10〜100℃で1〜50時間反応させる。In the present invention, the 3-alkoxyaniline derivative represented by the chemical formula (1) can be synthesized, for example, as follows. That is, the chemical formula (2)
(Wherein, R 1 is the same as described above) and 1 to 3 mol of the chemical formula (3) (in the formula, X represents a halogen atom; R 2 is the same as described above) based on 1 mol of the compound represented by the formula: The compound shown is reacted in a solvent such as an alcohol such as methanol, ethanol or isopropanol, or a cyclic ether such as 1,4-dioxane or tetrahydrofuran (THF) at 10 to 100 ° C. for 1 to 50 hours.
【化3】 Embedded image
【化4】 次に、常法により精製を行い、化学式(4)(式中、R
1及びR2は前記に同じ。)で示される化合物を得る。Embedded image Next, purification is carried out by a conventional method, and the chemical formula (4) (wherein R
1 and R 2 are as defined above. ) Is obtained.
【化5】 Embedded image
【0020】次に、前記化学式(4)で示される化合物
1モルに対して1〜3モルの化学式(5)(式中、R4
及びR5は各々水素原子又はアルキル基を、R6はアル
キル基を示す。)で示される化合物を、メタノール、エ
タノール、又はイソプロパノールなどのアルコール類、
或いは1,4−ジオキサン、テトラヒドロフラン(TH
F)などの環状エーテル類等に水を混ぜたものに溶解す
る。Next, 1 to 3 mol of the compound of the formula (5) (wherein R 4
And R 5 each represent a hydrogen atom or an alkyl group, and R 6 represents an alkyl group. ), Alcohols such as methanol, ethanol or isopropanol,
Alternatively, 1,4-dioxane, tetrahydrofuran (TH
Dissolve in a mixture of cyclic ethers such as F) and water.
【化6】 これに前記化学式(4)で示される化合物1当量に対し
て1〜3当量の、例えば水酸化ナトリウム、水酸化カリ
ウムなどのアルカリ金属水酸化物、又は例えば炭酸ナト
リウム、炭酸カリウムなどのアルカリ金属炭酸塩を添加
し、10〜100℃で1〜50時間反応させた後、常法
により精製を行い、化学式(6)(式中、R1、R2、
R4、R5及びR6は前記に同じ。)で示される化合物
を得る。Embedded image 1 to 3 equivalents of an alkali metal hydroxide such as sodium hydroxide or potassium hydroxide or alkali metal carbonate such as sodium carbonate or potassium carbonate for 1 equivalent of the compound represented by the chemical formula (4) After adding a salt and reacting at 10 to 100 ° C. for 1 to 50 hours, purification is carried out by a conventional method, and the chemical formula (6) (where R 1 , R 2 ,
R 4 , R 5 and R 6 are the same as described above. ) Is obtained.
【化7】 Embedded image
【0021】次に、化学式(6)で示される化合物1モ
ルに対して1〜5モルの水酸化ナトリウム水溶液を加
え、室温で1〜10時間反応させた後、塩酸を添加して
酸性にし、常法により精製することにより、本発明の3
−アルコキシアニリン誘導体又はその塩が得られる。Next, an aqueous solution of 1 to 5 mol of sodium hydroxide is added to 1 mol of the compound represented by the chemical formula (6), and the mixture is reacted at room temperature for 1 to 10 hours. By purifying by the conventional method, 3
-An alkoxyaniline derivative or a salt thereof is obtained.
【0022】なお、化学式(1)のR2が水素原子であ
る化合物を合成する場合には、前記した合成法の反応工
程のうち、必要な工程のみを行えばよい。In the case of synthesizing a compound in which R 2 in the chemical formula (1) is a hydrogen atom, only necessary steps among the reaction steps of the above-described synthesis method need to be performed.
【0023】また、本発明の3−アルコキシアニリン誘
導体又はその塩の製造に用いられる前記化学式(2)で
示される化合物は、広く市販されているので、市販品を
そのまま用いればよい。The compound represented by the chemical formula (2) used for producing the 3-alkoxyaniline derivative or a salt thereof according to the present invention is widely commercially available, and therefore, a commercially available product may be used as it is.
【0024】本発明の酸化性物質の測定方法及び測定試
薬は、前記化学式(1)の3−アルコキシアニリン誘導
体又はその塩よりなる色原体及びカップラーを被酸化性
発色試薬として用いる又は含有させることを特徴とする
ものである。The method and reagent for measuring an oxidizing substance according to the present invention use or contain a chromogen and a coupler comprising the 3-alkoxyaniline derivative of the above formula (1) or a salt thereof as an oxidizable coloring reagent. It is characterized by the following.
【0025】本発明の3−アルコキシアニリン誘導体又
はその塩を色原体として使用し、カップラーと組み合わ
せて用いた場合、その呈色が極めて安定な色素を生成す
る。この色素は、生体試料中の共存物質による影響を抑
制できるものである。従って、本発明の3−アルコキシ
アニリン誘導体又はその塩は、酸化性物質の測定やペル
オキシダーゼ様物質の測定における被酸化性発色試薬の
色原体として好適である。When the 3-alkoxyaniline derivative of the present invention or a salt thereof is used as a chromogen and used in combination with a coupler, a colorant whose coloration is extremely stable is produced. This dye can suppress the influence of a coexisting substance in a biological sample. Therefore, the 3-alkoxyaniline derivative or a salt thereof of the present invention is suitable as a chromogen of an oxidizable color-forming reagent in the measurement of an oxidizing substance or the measurement of a peroxidase-like substance.
【0026】本発明の測定方法及び測定試薬を用いて測
定することができる生体成分としては、酵素反応により
直接又は間接的に生成する過酸化水素等の酸化性物質を
測定することにより測定することができる生体成分、又
はペルオキシダーゼ様物質等を挙げることができる。例
えば、尿酸、ブドウ糖、コレステロール、トリグリセラ
イド、リン脂質、コリンエステラーゼ等が挙げられる。The biological component which can be measured using the measuring method and the measuring reagent of the present invention is to measure by measuring an oxidizing substance such as hydrogen peroxide generated directly or indirectly by an enzymatic reaction. And a peroxidase-like substance. For example, uric acid, glucose, cholesterol, triglyceride, phospholipid, cholinesterase and the like can be mentioned.
【0027】また、本発明の測定方法及び測定試薬にお
ける試料としては、前記した生体成分を含むことが推測
され、その試料中の生体成分の存在の有無の測定、又は
生体成分濃度の測定を行おうとするもの等を挙げること
ができる。例えば、ヒト又は動物の血液、血清、血漿、
尿、精液、髄液、唾液、汗、涙、腹水、羊水等の体液;
ヒト若しくは動物の膵臓、肝臓等の臓器、毛髪、皮膚、
爪、筋肉、又は神経組織等の抽出液;ヒト又は動物の糞
便の抽出液又は懸濁液;細胞の抽出液;植物の抽出液等
が挙げられる。Further, it is presumed that the sample in the measuring method and the measuring reagent of the present invention contains the above-mentioned biological component, and the presence or absence of the biological component in the sample or the measurement of the biological component concentration is performed. And the like. For example, human or animal blood, serum, plasma,
Body fluids such as urine, semen, cerebrospinal fluid, saliva, sweat, tears, ascites, and amniotic fluid;
Human or animal pancreas, organs such as liver, hair, skin,
Extracts of nails, muscles, or nerve tissues, etc .; human or animal feces extracts or suspensions; cell extracts; plant extracts, and the like.
【0028】本発明の測定方法及び測定試薬において
は、本発明の3−アルコキシアニリン誘導体又はその塩
と、例えば、4−アミノアンチピリン又はその誘導体、
フェニレンジアミン、3−メチル−2−ベンゾチアゾリ
ノンヒドラゾン(MBTH)等のカップラーとを組み合
わせたものを被酸化性発色試薬として用いる以外は、従
来より公知の酵素学的測定方法及び測定試薬、例えば、
過酸化水素を生成する酸化酵素を用いて、生体成分から
直接過酸化水素を生成させるか、又は生体成分から酵素
反応によって得られた生成物に過酸化水素を生成する酸
化酵素を作用させて、間接的に過酸化水素を生成させ、
生成した過酸化水素をペルオキシダーゼ及び被酸化性発
色試薬と混合、接触させて発色系に導き、酸化縮合反応
により被酸化性発色試薬から生成した色素を光学的に測
定することにより生体成分を測定する測定方法及び測定
試薬に従えばよい。また、本発明の測定方法及び測定試
薬におけるカップラーとしては、特に、4−アミノアン
チピリン又はその誘導体が好適である。In the measuring method and the measuring reagent of the present invention, the 3-alkoxyaniline derivative of the present invention or a salt thereof, for example, 4-aminoantipyrine or a derivative thereof,
A conventionally known enzymatic measurement method and a measurement reagent, for example, except that a combination with a coupler such as phenylenediamine and 3-methyl-2-benzothiazolinone hydrazone (MBTH) is used as an oxidizable color reagent. ,
Using an oxidase that generates hydrogen peroxide, directly generate hydrogen peroxide from a biological component, or by reacting an oxidase that generates hydrogen peroxide on a product obtained by an enzymatic reaction from the biological component, Indirectly producing hydrogen peroxide,
The resulting hydrogen peroxide is mixed with peroxidase and an oxidizable color reagent, brought into contact with the chromogenic system, and a biological component is measured by optically measuring a dye generated from the oxidizable color reagent by an oxidative condensation reaction. What is necessary is just to follow a measuring method and a measuring reagent. As the coupler in the measuring method and the measuring reagent of the present invention, 4-aminoantipyrine or a derivative thereof is particularly preferable.
【0029】本発明の測定方法及び測定試薬において、
用いられるペルオキシダーゼは、西洋ワサビ又は微生物
等由来のものを、20単位/L以上の濃度で用いること
が好ましい。また、被酸化性発色試薬の使用濃度は、色
原体としての本発明の3−アルコキシアニリン誘導体又
はその塩が、好ましくは0.05〜20mMの濃度範
囲、特に好ましくは0.2〜5mMの濃度範囲であり、
カップラーは好ましくは0.05〜10mMの濃度範
囲、特に好ましくは0.1〜5mMの濃度範囲で、適宜
組み合わせればよい。In the measuring method and the measuring reagent of the present invention,
The peroxidase used is preferably derived from horseradish or a microorganism at a concentration of 20 units / L or more. The concentration of the oxidizable color forming reagent used is such that the 3-alkoxyaniline derivative of the present invention or a salt thereof as a chromogen preferably has a concentration in the range of 0.05 to 20 mM, particularly preferably 0.2 to 5 mM. Concentration range,
The couplers may be suitably combined in a concentration range of preferably 0.05 to 10 mM, particularly preferably 0.1 to 5 mM.
【0030】本発明の測定方法及び測定試薬において、
測定反応液のpHは、pH4.0〜10.0の範囲にあ
ることが好ましく、pH6.0〜8.0の範囲が特に好
ましい。また、緩衝剤としては、前記のpH範囲に緩衝
能がある緩衝剤を適宜用いることが好ましい。このよう
な緩衝剤としては、例えば、リン酸緩衝液、Tris、
イミダゾール、グリシルグリシン、MES、Bis−T
ris、ADA、ACES、Bis−Trisプロパ
ン、PIPES、MOPSO、MOPS、BES、HE
PES、TES、DIPSO、TAPSO、POPS
O、HEPPS、HEPPSO、Tricine、Bi
cine、TAPS等を挙げることができる。In the measuring method and the measuring reagent of the present invention,
The pH of the measurement reaction solution is preferably in the range of pH 4.0 to 10.0, and particularly preferably in the range of pH 6.0 to 8.0. As the buffer, it is preferable to appropriately use a buffer having a buffering capacity in the above-mentioned pH range. Such buffers include, for example, phosphate buffer, Tris,
Imidazole, glycylglycine, MES, Bis-T
ris, ADA, ACES, Bis-Tris propane, PIPES, MOPSO, MOPS, BES, HE
PES, TES, DIPSO, TAPSO, POPS
O, HEPPS, HEPPSO, Tricine, Bi
cine, TAPS and the like.
【0031】本発明の測定方法及び測定試薬には、更
に、安定化剤、活性化剤、防腐剤、又は他の試薬成分等
を含有させてもよい。The measuring method and the measuring reagent of the present invention may further contain a stabilizer, an activator, a preservative, or other reagent components.
【0032】安定化剤、活性化剤としては、例えば、補
酵素、界面活性剤、アルカリ金属イオン等を含有させて
もよい。As the stabilizing agent and the activating agent, for example, a coenzyme, a surfactant, an alkali metal ion and the like may be contained.
【0033】また、防腐剤としては、例えば、安息香
酸、合成抗菌剤又は抗生物質等を添加してもよい。As a preservative, for example, benzoic acid, a synthetic antibacterial agent or an antibiotic may be added.
【0034】本発明の測定方法及び測定試薬において、
酸化性物質とは、前記色原体及び前記カップラーととも
にペルオキシダーゼの作用を受け、色素を生成する物質
をいう。このような物質としては、例えば、過酸化水
素、過ヨウ素酸等を挙げることができる。In the measuring method and the measuring reagent of the present invention,
The oxidizing substance refers to a substance that undergoes the action of peroxidase together with the chromogen and the coupler to generate a dye. Such substances include, for example, hydrogen peroxide, periodic acid and the like.
【0035】本発明の3−アルコキシアニリン誘導体又
はその塩は、カップラーとの組み合わせにより、ペルオ
キシダーゼ様物質の測定にも用いることができる。ここ
で、ペルオキシダーゼ様物質とは、前記酸化性物質と前
記色原体と前記カップラーに作用して、色素を生成させ
る物質をいう。例えば、ペルオキシダーゼ、ヘモグロビ
ン、その他のヘム化合物等を挙げることができる。ま
た、本発明の3−アルコキシアニリン誘導体又はその塩
は、例えば、ペルオキシダーゼを標識化合物に用いた酵
素免疫測定法や、血清中のヘモグロビンを過酸化水素若
しくは過ヨウ素酸ナトリウムのような酸化性物質を用い
て測定する場合等にも用いることができる。The 3-alkoxyaniline derivative of the present invention or a salt thereof can be used for measurement of a peroxidase-like substance in combination with a coupler. Here, the peroxidase-like substance refers to a substance that acts on the oxidizing substance, the chromogen, and the coupler to generate a dye. For example, peroxidase, hemoglobin, other heme compounds and the like can be mentioned. Further, the 3-alkoxyaniline derivative or a salt thereof of the present invention may be, for example, an enzyme immunoassay using peroxidase as a labeling compound, or an oxidizing substance such as hydrogen peroxide or sodium periodate in hemoglobin in serum. It can also be used in the case of using and measuring.
【0036】本発明の測定試薬において、試薬の形状と
しては、液状試薬、凍結乾燥製剤、若しくは試験片又は
フィルム方式などの担体を用いるもの等、どのような形
状のものであってもよい。In the measuring reagent of the present invention, the shape of the reagent may be any shape such as a liquid reagent, a lyophilized preparation, a test piece or a film type carrier.
【0037】[0037]
【実施例】以下、実施例により本発明をより具体的に詳
述するが、本発明はこれらの実施例によって何ら限定さ
れるものではない。EXAMPLES Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
【0038】[実施例1] N−(2−カルボキシエチ
ル)−N−エチル−3−メトキシアニリン〔本発明化合
物〕の合成 60%水素化ナトリウム34.1gを1,4−ジオキサ
ン720mLに懸濁させ、80℃になるまで加熱し、こ
れにm−アニシジン100gを1時間かけて滴下し、次
いで臭化エチル92.7gを1時間かけて滴下した後、
100℃で8時間反応させた。反応終了後にこれを放冷
し、水5Lを加えた後、酢酸エチル3Lで抽出し、濃縮
を行った。Example 1 Synthesis of N- (2-carboxyethyl) -N-ethyl-3-methoxyaniline [compound of the present invention] 34.1 g of 60% sodium hydride was suspended in 720 mL of 1,4-dioxane. And heated to 80 ° C., to which 100 g of m-anisidine was added dropwise over 1 hour, and then 92.7 g of ethyl bromide was added dropwise over 1 hour.
The reaction was performed at 100 ° C. for 8 hours. After completion of the reaction, the mixture was allowed to cool, 5 L of water was added, and the mixture was extracted with 3 L of ethyl acetate and concentrated.
【0039】次に、減圧蒸留し、油状のN−エチル−3
−メトキシアニリン92gを得た。次いで、このN−エ
チル−3−メトキシアニリン90gに、アクリル酸メチ
ル59.2gと酢酸5.5gを加え、110℃で20時
間還流した。濃縮後、シリカゲルカラム(酢酸エチル:
ヘキサン=1:9の溶出溶媒を使用)により精製し、油
状のN−(2−カルボキシエチル)−N−エチル−3−
メトキシアニリンメチルエステル90gを得た。Next, distillation was performed under reduced pressure to obtain oily N-ethyl-3.
-92 g of methoxyaniline were obtained. Next, 59.2 g of methyl acrylate and 5.5 g of acetic acid were added to 90 g of the N-ethyl-3-methoxyaniline, and the mixture was refluxed at 110 ° C. for 20 hours. After concentration, a silica gel column (ethyl acetate:
Hexane = 1: 9 using an elution solvent) to give oily N- (2-carboxyethyl) -N-ethyl-3-
90 g of methoxyaniline methyl ester were obtained.
【0040】このN−(2−カルボキシエチル)−N−
エチル−3−メトキシアニリンメチルエステル90gに
2N水酸化ナトリウム280mLを加えた後、2時間還
流した。これを氷冷し、濃塩酸60mLを加えpH4.
0とした。そして、酢酸エチル1Lを用いて抽出、濃縮
を行い、N−(2−カルボキシエチル)−N−エチル−
3−メトキシアニリン〔CEMO;本発明化合物〕26
gを得た。This N- (2-carboxyethyl) -N-
After adding 280 mL of 2N sodium hydroxide to 90 g of ethyl-3-methoxyaniline methyl ester, the mixture was refluxed for 2 hours. This was cooled on ice, and 60 mL of concentrated hydrochloric acid was added thereto to adjust the pH to 4.
0 was set. Then, extraction and concentration were performed using 1 L of ethyl acetate, and N- (2-carboxyethyl) -N-ethyl-
3-methoxyaniline [CEMO; compound of the present invention] 26
g was obtained.
【0041】[実施例2] 尿酸測定試薬における呈色
の安定性の確認 実施例1にて合成したN−(2−カルボキシエチル)−
N−エチル−3−メトキシアニリン〔CEMO;本発明
化合物〕又は他のアニリン誘導体を色原体として含有す
る尿酸測定用の第1試薬、及びカップラーである4−ア
ミノアンチピリンを含有する尿酸測定用の第2試薬より
構成される尿酸測定試薬を調製し、測定時の呈色の安定
性を確認した。[Example 2] Confirmation of color stability in uric acid measurement reagent N- (2-carboxyethyl)-synthesized in Example 1
A first reagent for measuring uric acid containing N-ethyl-3-methoxyaniline [CEMO; the compound of the present invention] or another aniline derivative as a chromogen, and a first reagent for measuring uric acid containing 4-aminoantipyrine as a coupler. A uric acid measurement reagent composed of the second reagent was prepared, and the stability of coloration at the time of measurement was confirmed.
【0042】(1)試薬の調製 本発明・尿酸測定用第1試薬の調製:下記の測定試薬
成分をそれぞれ記載の濃度になるように純水に溶解し、
pH7.0(20℃)に調整した。 測定試薬成分 濃 度 3−(N−モルホリン)プロパンスルホン酸〔MOPS〕 50mM N−(2−カルボキシエチル)−N−エチル −3−メトキシアニリン〔CEMO・色原体〕 1mM ペルオキシダーゼ 1000単位/L アスコルビン酸オキシダーゼ 1500単位/L 界面活性剤 0.2%(1) Preparation of Reagent Preparation of the First Reagent for Uric Acid Measurement of the Present Invention: The following reagent components for measurement were dissolved in pure water so as to have the respective concentrations described below.
The pH was adjusted to 7.0 (20 ° C). Reagent components for measurement Concentration 3- (N-morpholine) propanesulfonic acid [MOPS] 50 mM N- (2-carboxyethyl) -N-ethyl-3-methoxyaniline [CEMO / chromogen] 1 mM peroxidase 1000 units / L ascorbin Acid oxidase 1500 units / L surfactant 0.2%
【0043】対照1・尿酸測定用第1試薬の調製:色
原体をN−(2−カルボキシエチル)−N−エチル−3
−メチルアニリン〔略名:CEMB〕に変えること以外
は、前記の本発明の尿酸測定用第1試薬と同じ測定試
薬成分及び濃度で調製を行った。Control 1: Preparation of first reagent for uric acid measurement: Chromogen was converted to N- (2-carboxyethyl) -N-ethyl-3
Preparation was performed using the same reagent components and concentrations as those of the above-mentioned first reagent for measuring uric acid of the present invention, except that -methylaniline (abbreviation: CEMB) was used.
【0044】対照2・尿酸測定用第1試薬の調製 色原体をN−(2−ヒドロキシ−3−スルホプロピル)
−N−エチル−3,5−ジメチルアニリン〔略名:MA
OS〕に変えること以外は、前記の本発明の尿酸測定
用第1試薬と同じ測定試薬成分及び濃度で調製を行っ
た。Control 2: Preparation of First Reagent for Uric Acid Measurement The chromogen was N- (2-hydroxy-3-sulfopropyl)
-N-ethyl-3,5-dimethylaniline [abbreviation: MA
OS] was prepared using the same reagent components and concentrations as those of the first reagent for measuring uric acid of the present invention described above.
【0045】対照3・尿酸測定用第1試薬の調製 色原体をN−エチル−N−(2−ヒドロキシ−3−スル
ホプロピル)−3−メチルアニリン〔略名:TOOS〕
に変えること以外は、前記の本発明の尿酸測定用第1
試薬と同じ測定試薬成分及び濃度で調製を行った。Control 3 Preparation of First Reagent for Uric Acid Measurement The chromogen was converted to N-ethyl-N- (2-hydroxy-3-sulfopropyl) -3-methylaniline [abbreviation: TOOS]
Except for changing to the above, the first method for measuring uric acid of the present invention described above.
Preparation was performed using the same measurement reagent components and concentrations as the reagents.
【0046】対照4・尿酸測定用第1試薬の調製 色原体をN−(2−ヒドロキシ−3−スルホプロピル)
−3,5−ジメトキシアニリンナトリウム〔略名:HD
AOS〕に変えること以外は、前記の本発明の尿酸測
定用第1試薬と同じ測定試薬成分及び濃度で調製を行っ
た。Control 4 Preparation of First Reagent for Uric Acid Measurement The chromogen was converted to N- (2-hydroxy-3-sulfopropyl)
-3,5-dimethoxyaniline sodium [abbreviation: HD
AOS] was prepared using the same reagent components and concentrations as those of the above-mentioned first reagent for measuring uric acid of the present invention, except for changing to AOS].
【0047】対照5・尿酸測定用第1試薬の調製 色原体をN−(2−スルホプロピル)−N−エチル−3
−メトキシアニリン〔略名:ADPS〕に変えること以
外は、前記の本発明の尿酸測定用第1試薬と同じ測定
試薬成分及び濃度で調製を行った。Control 5 Preparation of First Reagent for Uric Acid Measurement The chromogen was converted to N- (2-sulfopropyl) -N-ethyl-3.
Preparation was performed using the same reagent components and concentrations as in the above-described first reagent for measuring uric acid of the present invention, except that -methoxyaniline (abbreviation: ADPS) was used.
【0048】なお、本発明及び対照の尿酸測定用第1試
薬において色原体として用いた化合物を表1に示した。The compounds used as chromogens in the present invention and the control first reagent for uric acid measurement are shown in Table 1.
【0049】[0049]
【表1】 [Table 1]
【0050】尿酸測定用第2試薬の調製 下記の測定試薬成分をそれぞれ記載の濃度になるように
純水に溶解し、pH7.0(20℃)に調整した。 測定試薬成分 濃 度 3−(N−モルホリン)プロパンスルホン酸〔MOPS〕 50mM 4−アミノアンチピリン(カップラー) 2.5mM ウリカーゼ 1000単位/L 界面活性剤 0.2%Preparation of Second Reagent for Uric Acid Measurement The following reagent components for measurement were dissolved in pure water so as to have the concentrations described, respectively, and adjusted to pH 7.0 (20 ° C.). Measurement reagent components Concentration 3- (N-morpholine) propanesulfonic acid [MOPS] 50 mM 4-aminoantipyrine (coupler) 2.5 mM uricase 1000 units / L surfactant 0.2%
【0051】(2)呈色の安定性の確認 純水90mLに炭酸リチウム6mgを溶解し、さらに尿
酸15mgを添加して完全溶解した。これを純水で全量
を100mLにして、尿酸濃度15mg/dLの試料を
作製した。この試料中の尿酸値を、前記(1)で調製し
た、本発明及び対照1〜5の尿酸測定用第1試薬、並び
に第2試薬の各々の試薬にて測定し、各試薬を用いた場
合の呈色の安定性を確認した。(2) Confirmation of Color Stability 6 mg of lithium carbonate was dissolved in 90 mL of pure water, and 15 mg of uric acid was added to completely dissolve it. This was made up to 100 mL with pure water to prepare a sample having a uric acid concentration of 15 mg / dL. The uric acid level in this sample was measured with each of the first and second reagents for measuring uric acid of the present invention and Controls 1 to 5 prepared in (1) above, and the respective reagents were used. The stability of the coloring was confirmed.
【0052】この試料中の尿酸の測定は、日立製作所製
7150形自動分析装置にて行い、試料5μLに尿酸測
定用第1試薬を320μL加え37℃で5分間反応させ
た後、尿酸測定用第2試薬を80μL添加して37℃で
反応を開始させた。主波長600nm及び副波長700
nmにおける第2試薬添加2分後(35ポイント)の吸
光度と第2試薬添加5分後(50ポイント)の吸光度を
測定した。The measurement of uric acid in this sample was carried out by an automatic analyzer 7150 manufactured by Hitachi, Ltd., and 320 μL of a first reagent for uric acid measurement was added to 5 μL of the sample, and reacted at 37 ° C. for 5 minutes. The reaction was started at 37 ° C. by adding 80 μL of the two reagents. Main wavelength 600 nm and sub wavelength 700
The absorbance in nm at 2 minutes after the addition of the second reagent (35 points) and the absorbance at 5 minutes after the addition of the second reagent (50 points) were measured.
【0053】(3)結果 各尿酸測定試薬における呈色の安定性に関する結果を表
2に示した。(3) Results Table 2 shows the results concerning the stability of coloration of each uric acid measurement reagent.
【0054】[0054]
【表2】 [Table 2]
【0055】この表より、本発明化合物を色原体として
用いた場合、吸光度は殆ど変化していない。これに対し
て、対照1〜3の尿酸測定用第1試薬を用いた場合は、
いずれも吸光度が低下してしまっていることが分かる。
これらのことにより、本発明化合物よりなる色原体及び
カップラーを被酸化性発色試薬として含有する尿酸測定
試薬は、呈色の安定性が極めて高いことが確かめられ
た。As can be seen from the table, when the compound of the present invention was used as a chromogen, the absorbance hardly changed. In contrast, when the first reagent for uric acid measurement of Controls 1 to 3 was used,
In each case, it can be seen that the absorbance has decreased.
From these, it was confirmed that the uric acid measurement reagent containing the chromogen and the coupler comprising the compound of the present invention as an oxidizable color-forming reagent has extremely high color stability.
【0056】[実施例3] 尿酸測定時における試料中
の共存物質の影響の確認 本発明化合物又は他のアニリン誘導体を色原体として含
有する尿酸測定用の第1試薬、及びカップラーである4
−アミノアンチピリンを含有する尿酸測定用の第2試薬
より構成される尿酸測定試薬を調製し、試料中に含まれ
る共存物質の影響について検討した。Example 3 Confirmation of the Influence of Coexisting Substances in the Sample at the Time of Uric Acid Measurement The first reagent for measuring uric acid containing the compound of the present invention or another aniline derivative as a chromogen, and a coupler 4
A uric acid measurement reagent composed of a second reagent for uric acid measurement containing aminoantipyrine was prepared, and the effect of coexisting substances contained in the sample was examined.
【0057】(1)試薬 本発明・尿酸測定用第1試薬:前記実施例2ので調
製した尿酸測定用第1試薬をそのまま用いた。(1) Reagent The first reagent for measuring uric acid of the present invention: The first reagent for measuring uric acid prepared in Example 2 was used as it was.
【0058】対照1・尿酸測定用第1試薬の調製:前
記実施例2ので調製した尿酸測定用第1試薬をそのま
ま用いた。Control 1: Preparation of first reagent for uric acid measurement: The first reagent for uric acid measurement prepared in Example 2 was used as it was.
【0059】対照2・尿酸測定用第1試薬の調製 前記実施例2ので調製した尿酸測定用第1試薬をその
まま用いた。Control 2 Preparation of First Reagent for Uric Acid Measurement The first reagent for uric acid measurement prepared in Example 2 was used as it was.
【0060】対照3・尿酸測定用第1試薬の調製 前記実施例2ので調製した尿酸測定用第1試薬をその
まま用いた。Control 3 Preparation of First Reagent for Uric Acid Measurement The first reagent for uric acid measurement prepared in Example 2 was used as it was.
【0061】尿酸測定用第2試薬の調製 前記実施例2ので調製した尿酸測定用第2試薬をその
まま用いた。Preparation of second reagent for uric acid measurement The second reagent for uric acid measurement prepared in Example 2 was used as it was.
【0062】(2)試料の作製 ビリルビン添加試料 ヒト血清9mLに、ビリルビン濃度が200mg/dL
の干渉チェックA・ビリルビンC(国際試薬社製)1m
Lを混合し、ビリルビン20mg/dLを添加したビリ
ルビン添加試料とした。 アスコルビン酸添加試料 ヒト血清9mLに、アスコルビン酸濃度が2000mg
/dLのアスコルビン酸水溶液1mLを混合し、アスコ
ルビン酸200mg/dLを添加したアスコルビン酸添
加試料とした。 ヘモグロビン添加試料 ヒト血清9mLに、ヘモグロビン濃度が5000mg/
dLの干渉チェックA・ヘモグロビン(国際試薬社製)
1mLを混合し、ヘモグロビン500mg/dLを添加
したヘモグロビン添加試料とした。 対照用試料 ヒト血清9mLに、純水1mLを混合し、対照用試料と
した。なお、この対照用試料中の尿酸濃度と、前記のビ
リルビン添加試料、アスコルビン酸添加試料、ヘモグロ
ビン添加試料中の尿酸濃度は同じである。 尿酸標準液 純水90mLに炭酸リチウム6mgを溶解し、さらに尿
酸15mgを添加して完全溶解した。純水で全量を10
0mLにして、尿酸濃度15mg/dLの尿酸標準液と
した。(2) Preparation of sample Bilirubin-added sample Bilirubin concentration of 200 mg / dL was added to 9 mL of human serum.
Interference check A ・ Bilirubin C (manufactured by Kokusai Reagents) 1m
L was mixed to obtain a bilirubin-added sample to which bilirubin 20 mg / dL was added. Ascorbic acid-added sample Ascorbic acid concentration of 2000 mg in 9 mL of human serum
/ DL of an aqueous solution of ascorbic acid (1 mL) was mixed to obtain an ascorbic acid-added sample to which ascorbic acid (200 mg / dL) was added. Hemoglobin-added sample A hemoglobin concentration of 5000 mg /
dL interference check A hemoglobin (manufactured by International Reagents)
1 mL was mixed to obtain a hemoglobin-added sample to which 500 mg / dL of hemoglobin was added. Control Sample 9 mL of human serum was mixed with 1 mL of pure water to prepare a control sample. The uric acid concentration in the control sample is the same as the uric acid concentration in the bilirubin-added sample, ascorbic acid-added sample, and hemoglobin-added sample. Uric acid standard solution 6 mg of lithium carbonate was dissolved in 90 mL of pure water, and 15 mg of uric acid was further added to completely dissolve it. 10 volumes with pure water
The volume was adjusted to 0 mL to obtain a uric acid standard solution having a uric acid concentration of 15 mg / dL.
【0063】(3)試料中の共存物質による測定値への
影響の確認 前記(2)で作製した4種類の試料(ビリルビン添加試
料、アスコルビン酸添加試料、ヘモグロビン添加試料、
対照用試料)中の尿酸値を、前記(1)で調製した、本
発明及び対照1〜3の尿酸測定用第1試薬、並びに第2
試薬の各々の試薬にて測定し、本発明試薬、対照1〜3
の試薬を用いた場合の試料中の共存物質による影響を確
認した。(3) Confirmation of the effect of the coexisting substance in the sample on the measured value The four types of samples (bilirubin-added sample, ascorbic acid-added sample, hemoglobin-added sample,
The uric acid value in the control sample) was determined using the first reagent for uric acid measurement of the present invention and Controls 1 to 3 prepared in (1) above, and
The measurement was performed with each of the reagents.
The effect of the coexisting substance in the sample when using the above reagent was confirmed.
【0064】前記(2)の試料中の尿酸の測定は、日立
製作所製7150形自動分析装置にて行い、試料5μL
に尿酸測定用第1試薬を320μL加え37℃で5分間
反応させた後、尿酸測定用第2試薬を80μL添加して
37℃で反応を開始させた。主波長600nm及び副波
長は800nmにおける第2試薬添加直前(24ポイン
ト)、及び第2試薬添加5分後(50ポイント)の吸光
度の増加分より、既知濃度の尿酸標準液を測定した時の
吸光度との比例計算によって尿酸値を求めた。なお、純
水を試料とした時の吸光度を試薬盲検値として、第2試
薬添加直前の吸光度及び第2試薬添加5分後の吸光度よ
り試薬盲検値を差し引いた吸光度を尿酸値の算出に用い
た。The measurement of uric acid in the sample (2) was carried out using an automatic analyzer 7150 manufactured by Hitachi, Ltd.
After adding 320 μL of a uric acid measurement first reagent to the mixture and reacting at 37 ° C. for 5 minutes, 80 μL of a uric acid measurement second reagent was added and the reaction was started at 37 ° C. The main wavelength of 600 nm and the sub-wavelength are the absorbance at the time of measuring the uric acid standard solution of a known concentration from the increase in absorbance at 800 nm immediately before the addition of the second reagent (24 points) and 5 minutes after the addition of the second reagent (50 points). The uric acid value was determined by proportional calculation with The absorbance obtained when pure water was used as the sample was used as the reagent blank value, and the absorbance obtained by subtracting the reagent blank value from the absorbance immediately before the addition of the second reagent and the absorbance 5 minutes after the addition of the second reagent was used to calculate the uric acid value. Using.
【0065】(4)結果 本発明の尿酸測定用第1試薬及び対照1〜3の尿酸測定
用第1試薬並びに尿酸測定用第2試薬を用いて、前記し
た4種類の試料(ビリルビン添加試料、アスコルビン酸
添加試料、ヘモグロビン添加試料、対照用試料)中の尿
酸を測定した時の測定結果を表3に示した。なお、表中
の上段は測定で得られた尿酸測定値、下段はこの尿酸測
定値の対照用試料の測定値に対する百分率を示した。(4) Results Using the first reagent for measuring uric acid of the present invention, the first reagent for measuring uric acid of Controls 1 to 3, and the second reagent for measuring uric acid, the four types of samples described above (bilirubin-added sample, Table 3 shows the measurement results when uric acid in the ascorbic acid-added sample, hemoglobin-added sample, and control sample) was measured. In the table, the upper part shows the measured value of uric acid obtained by the measurement, and the lower part shows the percentage of the measured value of uric acid with respect to the measured value of the control sample.
【0066】[0066]
【表3】 [Table 3]
【0067】この表より、対照1〜3の測定試薬では、
試料中の共存物質(ビリルビン、アスコルビン酸、ヘモ
グロビン)の影響があるのに対し、本発明の測定試薬で
は試料中の共存物質の影響を全く受けておらず、正確な
尿酸の測定値が得られることが確かめられた。From this table, it is found that the measurement reagents of Controls 1 to 3
While the coexisting substances (bilirubin, ascorbic acid, hemoglobin) in the sample are affected, the measurement reagent of the present invention is not affected by the coexisting substances in the sample at all, and an accurate uric acid measurement value can be obtained. It was confirmed that.
【0068】[実施例4] 総コレステロール測定試薬
における試料中の共存物質の影響の確認 本発明化合物又は他のアニリン誘導体を含有する総コレ
ステロール測定用の第1試薬、及びカップラーである4
−アミノアンチピリンを含有する総コレステロール測定
用の第2試薬より構成される総コレステロール測定試薬
を調製し、試料中に含まれる共存物質の影響について検
討した。Example 4 Confirmation of Influence of Coexisting Substances in Sample on Total Cholesterol Measurement Reagent A first reagent for measuring total cholesterol containing the compound of the present invention or another aniline derivative, and a coupler 4
A total cholesterol measuring reagent composed of a second reagent for measuring total cholesterol containing aminoantipyrine was prepared, and the effect of coexisting substances contained in the sample was examined.
【0069】(1)試薬の調製 総コレステロール測定用第1試薬の調製 下記の測定試薬成分をそれぞれ記載の濃度になるように
純水に溶解し、pH7.0(20℃)に調整した。 測定試薬成分 濃 度 N−(2−アセトアミド)イミノ二酢酸〔ADA〕 100mM 4−アミノアンチピリン(カップラー) 0.44mM コレステロールエステラーゼ 400単位/L アスコルビン酸オキシダーゼ 300単位/L 界面活性剤 0.1%(1) Preparation of Reagent Preparation of First Reagent for Measurement of Total Cholesterol The following reagent components for measurement were dissolved in pure water so as to have the concentrations described respectively, and the pH was adjusted to 7.0 (20 ° C.). Measurement reagent components Concentration N- (2-acetamido) iminodiacetic acid [ADA] 100 mM 4-aminoantipyrine (coupler) 0.44 mM cholesterol esterase 400 units / L ascorbate oxidase 300 units / L surfactant 0.1%
【0070】本発明・総コレステロール測定用第2試
薬の調製 下記の測定試薬成分をそれぞれ記載の濃度になるように
純水に溶解し、pH7.0(20℃)に調整した。 測定試薬成分 濃 度 N−トリス(ヒドロキシメチル)メチル −2−アミノエタンスルホン酸〔TES〕 20mM N−(2−カルボキシエチル)−N−エチル −3−メトキシアニリン〔CEMO・色原体〕 1mM コレステロールオキシダーゼ 300単位/L ペルオキシダーゼ 1600単位/L アジ化ナトリウム 0.01% 界面活性剤 0.1%Preparation of Second Reagent for Measurement of Total Cholesterol of the Present Invention The following reagent components for measurement were dissolved in pure water so as to have the concentrations described respectively, and adjusted to pH 7.0 (20 ° C.). Measurement reagent components Concentration N-tris (hydroxymethyl) methyl-2-aminoethanesulfonic acid [TES] 20 mM N- (2-carboxyethyl) -N-ethyl-3-methoxyaniline [CEMO / chromogen] 1 mM cholesterol Oxidase 300 units / L Peroxidase 1600 units / L Sodium azide 0.01% Surfactant 0.1%
【0071】対照・総コレステロール測定用第2試薬
の調製 色原体をN−(2−スルホプロピル)−N−エチル−3
−メトキシアニリン〔略名:ADPS〕に変えること以
外は、前記の本発明の総コレステロール測定用第2試
薬と同じ測定試薬成分及び濃度で調製を行った。Preparation of Control / Second Reagent for Measurement of Total Cholesterol The chromogen was converted to N- (2-sulfopropyl) -N-ethyl-3.
Preparation was performed using the same measurement reagent components and concentrations as those of the above-mentioned second reagent for measuring total cholesterol of the present invention, except that -methoxyaniline (abbreviation: ADPS) was used.
【0072】(2)試料の作製 ビリルビン添加試料 ヒト血清9mLに、ビリルビン濃度が500mg/dL
の干渉チェックA・ビリルビンC(国際試薬社製)1m
Lを混合し、ビリルビン50mg/dLを添加したビリ
ルビン添加試料とした。(2) Preparation of sample Bilirubin-added sample Bilirubin concentration of 500 mg / dL was added to 9 mL of human serum.
Interference check A ・ Bilirubin C (manufactured by Kokusai Reagents) 1m
L was mixed to obtain a bilirubin-added sample to which bilirubin 50 mg / dL was added.
【0073】対照用試料 ヒト血清9mLに、純水1mLを混合し、対照用試料と
した。なお、この対照用試料中の総コレステロール濃度
も、前記のビリルビン添加試料中の総コレステロール濃
度は同じである。Control Sample 9 mL of human serum was mixed with 1 mL of pure water to prepare a control sample. The total cholesterol concentration in the control sample is the same as the total cholesterol concentration in the bilirubin-added sample.
【0074】(3)試料中の共存物質による測定値への
影響の確認 前記(2)で作製した2種類の試料(ビリルビン添加試
料、対照用試料)中の総コレステロール値を、前記
(1)で調製した、総コレステロール測定用第1試薬並
びに、本発明及び対照の総コレステロール測定用第2試
薬の各々の試薬にて測定し、本発明の測定試薬、及び対
照の測定試薬を用いた場合の試料中の共存物質による影
響を確認した。(3) Confirmation of the influence of the coexisting substance in the sample on the measured value The total cholesterol value in the two types of samples (bilirubin-added sample and control sample) prepared in the above (2) was determined by the above (1). The measurement was performed using the first reagent for measuring total cholesterol and the second reagent for measuring total cholesterol of the present invention and the control prepared in the above, and the measurement reagent of the present invention and the control measuring reagent were used. The effect of coexisting substances in the sample was confirmed.
【0075】前記(2)の試料中の総コレステロールの
測定は、日立製作所製7150形自動分析装置にて行
い、試料4μLに総コレステロール測定用第1試薬を3
00μL加え37℃で5分間反応させた後、総コレステ
ロール測定用第2試薬を100μL添加して37℃で反
応を開始させた。主波長600nm及び副波長700n
mにおける第2試薬添加直前(24ポイント)、第2試
薬添加5分後(50ポイント)の吸光度の増加分より、
既知濃度の総コレステロール標準液を測定した時の吸光
度との比例計算によって総コレステロール値を求めた。
なお、純水を試料とした時の吸光度を試薬盲検値とし
て、第2試薬添加直前の吸光度及び第2試薬添加5分後
の吸光度より試薬盲検値を差し引いた吸光度を総コレス
テロール値の算出に用いた。The measurement of the total cholesterol in the sample of the above (2) was carried out by an automatic analyzer 7150 manufactured by Hitachi, Ltd., and the first reagent for total cholesterol measurement was added to 4 μL of the sample.
After adding 00 μL and reacting at 37 ° C. for 5 minutes, 100 μL of a second reagent for measuring total cholesterol was added and the reaction was started at 37 ° C. Main wavelength 600nm and sub wavelength 700n
m from the increase in absorbance immediately before the addition of the second reagent (24 points) and 5 minutes after the addition of the second reagent (50 points),
The total cholesterol value was determined by proportional calculation with the absorbance when measuring a known concentration of the total cholesterol standard solution.
The absorbance obtained when pure water was used as a sample was used as the reagent blank value, and the absorbance obtained by subtracting the reagent blank value from the absorbance immediately before the addition of the second reagent and the absorbance 5 minutes after the addition of the second reagent was used to calculate the total cholesterol value. It was used for.
【0076】(4)結果 総コレステロール測定用第1試薬及び本発明の総コレス
テロール測定用第2試薬並びに、対照の総コレステロー
ル測定用第2試薬を用いて、前記した2種類の試料中の
総コレステロールを測定した時の測定結果を表4に示し
た。なお、表中の上段は総コレステロールの測定で得ら
れた測定値、下段はこの総コレステロール測定値の対照
用試料の測定値に対する百分率を示した。(4) Results Using the first reagent for measuring total cholesterol, the second reagent for measuring total cholesterol of the present invention, and the second reagent for measuring total cholesterol as a control, total cholesterol in the two kinds of samples described above was used. Table 4 shows the results of the measurement. The upper row in the table shows the measured values obtained by measuring the total cholesterol, and the lower row shows the percentage of the total cholesterol measured value to the measured value of the control sample.
【0077】[0077]
【表4】 [Table 4]
【0078】この表より、対照の測定試薬では、ビリル
ビンによる負誤差が5%もあるのに対し、本発明の測定
試薬では、2%にとどまっていることが分かる。From the table, it can be seen that the negative error due to bilirubin is as high as 5% in the control measurement reagent, whereas it is only 2% in the measurement reagent of the present invention.
【0079】このことより、総コレステロール測定用第
1試薬、及び本発明の総コレステロール測定用第2試薬
による総コレステロールの測定は、ビリルビンによる影
響をほとんど受けておらず、正確な総コレステロール値
が得られることが確かめられた。From the above, the measurement of total cholesterol using the first reagent for measuring total cholesterol and the second reagent for measuring total cholesterol of the present invention was hardly affected by bilirubin, and an accurate total cholesterol value was obtained. It was confirmed that it could be done.
【0080】[実施例5] 気体の溶け込みによる試薬
の劣化防止効果の実証 アジ化物を気化するアジ化ナトリウム含有試薬、本発明
の測定試薬の組み合わせにおける、本発明測定試薬への
気化したアジ化物の溶け込みによる発色、劣化の度合い
を確かめた。Example 5 Demonstration of the Effect of Preventing the Deterioration of the Reagent by Dissolution of Gas The use of the sodium azide-containing reagent for vaporizing azide and the measurement reagent of the present invention, The degree of color development and deterioration due to penetration was confirmed.
【0081】(1)試薬の調製 アジ化ナトリウム含有試薬 下記の測定試薬成分をそれぞれ記載の濃度になるように
純水に溶解し、pH5.2(20℃)に調整した。 測定試薬成分 濃 度 N−(2−ヒドロキシエチルピペラジン) −N’−2−エタンスルホン酸[HEPES] 100mM アジ化ナトリウム 10mM(1) Preparation of Reagents Reagents containing sodium azide The following measurement reagent components were dissolved in pure water so as to have the respective concentrations described, and adjusted to pH 5.2 (20 ° C.). Measurement reagent component Concentration N- (2-hydroxyethylpiperazine) -N'-2-ethanesulfonic acid [HEPES] 100 mM Sodium azide 10 mM
【0082】本発明・尿酸測定用第1試薬の調製 下記の測定試薬成分をそれぞれ記載の濃度になるように
純水に溶解し、pH7.0(20℃)に調製した。 測定試薬成分 濃 度 N−(2−ヒドロキシエチルピペラジン) −N’−2−エタンスルホン酸[HEPES] 100mM N−(2−カルボキシエチル)−N−エチル −3−メトキシアニリン〔CEMO・色原体〕 2mM ペルオキシダーゼ 3000単位/L アスコルビン酸オキシダーゼ 3000単位/L 界面活性剤 0.2%Preparation of the First Reagent for Uric Acid Measurement of the Present Invention The following reagent components for measurement were dissolved in pure water so as to have the respective concentrations described below, and adjusted to pH 7.0 (20 ° C.). Measurement reagent components Concentration N- (2-hydroxyethylpiperazine) -N'-2-ethanesulfonic acid [HEPES] 100 mM N- (2-carboxyethyl) -N-ethyl-3-methoxyaniline [CEMO / chromogen ] 2 mM peroxidase 3000 units / L ascorbate oxidase 3000 units / L surfactant 0.2%
【0083】対照1・尿酸測定用第1試薬の調製 色原体をN−(2−ヒドロキシ−3−スルホプロピル)
−3,5−ジメトキシアニリンナトリウム〔略名:HD
AOS〕に変えること以外は、前記の本発明の尿酸測
定用第1試薬と同じ測定試薬成分及び濃度で調製を行っ
た。Control 1—Preparation of First Reagent for Uric Acid Measurement The chromogen was N- (2-hydroxy-3-sulfopropyl)
-3,5-dimethoxyaniline sodium [abbreviation: HD
AOS] was prepared using the same measurement reagent components and concentrations as the uric acid measurement first reagent of the present invention, except for changing to AOS].
【0084】対照2・尿酸測定用第1試薬の調製 色原体をN−エチル−N−(2−ヒドロキシ−3−スル
ホプロピル)−3,5−ジメトキシアニリン〔略名:D
AOS〕に変えること以外は、前記の本発明の尿酸測
定用第1試薬と同じ測定試薬成分及び濃度で調製を行っ
た。Control 2 Preparation of First Reagent for Uric Acid Measurement The chromogen was converted to N-ethyl-N- (2-hydroxy-3-sulfopropyl) -3,5-dimethoxyaniline [abbreviation: D
AOS] was prepared using the same measurement reagent components and concentrations as the uric acid measurement first reagent of the present invention, except for changing to AOS].
【0085】対照3・尿酸測定用第1試薬の調製 色原体をN−(2−カルボキシエチル)−N−エチル−
3,5−ジメトキシアニリン〔略名:CEDB〕に変え
ること以外は、前記の本発明の尿酸測定用第1試薬と
同じ測定試薬成分及び濃度で調製を行った。Control 3 Preparation of First Reagent for Uric Acid Measurement The chromogen was converted to N- (2-carboxyethyl) -N-ethyl-
The preparation was carried out with the same measuring reagent components and concentrations as the above-mentioned first reagent for measuring uric acid of the present invention, except that 3,5-dimethoxyaniline [abbreviation: CEDB] was used.
【0086】尿酸測定用第2試薬の調製 下記の測定試薬成分をそれぞれ記載の濃度になるように
純水に溶解し、pH7.0(20℃)に調整した。 測定試薬成分 濃 度 N−(2−ヒドロキシエチルピペラジン) −N’−2−エタンスルホン酸〔HEPES〕 100mM 4−アミノアンチピリン 2.5mM ウリカーゼ 1000単位/L 界面活性剤 0.2%Preparation of Second Uric Acid Measurement Reagent The following measurement reagent components were dissolved in pure water so as to have the respective concentrations described above, and the pH was adjusted to 7.0 (20 ° C.). Measurement reagent components Concentration N- (2-hydroxyethylpiperazine) -N'-2-ethanesulfonic acid [HEPES] 100 mM 4-aminoantipyrine 2.5 mM uricase 1000 units / L Surfactant 0.2%
【0087】(2)安定性検討のための試薬の保存 前記(1)で調製した、アジ化ナトリウム含有試薬、本
発明及び対照1〜3の尿酸測定用第1試薬、並びに第2
試薬を、図1のようにそれぞれ試験管(容量10mL、
長さ105mm、内径13mm)に分注し、下記の組み
合わせでポリ袋(135mm×85mm;チャック付
き)に入れ、チャックを閉めて密封し、25℃にて30
日間保存した。なお、各試験管の口に栓はしなかった。 1)本発明・尿酸測定用第1試薬、第2試薬及びアジ化
ナトリウム含有試薬 2)対照1・尿酸測定用第1試薬、第2試薬及びアジ化
ナトリウム含有試薬 3)対照2・尿酸測定用第1試薬、第2試薬及びアジ化
ナトリウム含有試薬 4)対照3・尿酸測定用第1試薬、第2試薬及びアジ化
ナトリウム含有試薬(2) Storage of Reagents for Stability Study The sodium azide-containing reagent prepared in the above (1), the first reagent for uric acid measurement of the present invention and Controls 1 to 3, and the second reagent
Reagents were placed in test tubes (volume 10 mL,
Dispense into 105 mm length, 13 mm inside diameter), put in a plastic bag (135 mm x 85 mm; with a zipper) in the following combination, close and seal the zipper, and seal at 25 ° C for 30
Saved for days. In addition, the mouth of each test tube was not plugged. 1) The present invention: the first reagent for measuring uric acid, the second reagent and the reagent containing sodium azide 2) the control 1 the first reagent for measuring uric acid, the second reagent and the reagent containing sodium azide 3) the control 2 for the measurement of uric acid First reagent, second reagent and sodium azide-containing reagent 4) Control 3-first reagent, second reagent and sodium azide-containing reagent for uric acid measurement
【0088】(3)保存した試薬の安定性の判定 保存開始時及び、保存1日後、5日後、12日後、17
日後、並びに30日後に、本発明及び対照1〜3の尿酸
測定用第1試薬が発色しているか否かを目視で判定し
た。(3) Judgment of stability of stored reagents At the start of storage, and after 1 day, 5 days, 12 days, and 17 days
After one day and 30 days, it was visually determined whether or not the first reagents for measuring uric acid of the present invention and Controls 1 to 3 were colored.
【0089】(4)安定性の判定結果 試薬の安定性について、発色の判定結果を表5に示し
た。(4) Results of Judgment of Stability Table 5 shows the results of judgment of color development regarding the stability of the reagent.
【0090】[0090]
【表5】 [Table 5]
【0091】この表より、対照1〜3の尿酸測定用第1
試薬は、保存5日後にして既に発色してしまっているの
に対して、本発明の尿酸測定用第1試薬は、保存30日
後でさえも発色していないことが分かる。From this table, it is found that the first to third uric acid measurements of Controls 1 to 3 were performed.
It can be seen that the reagent has already developed color 5 days after storage, whereas the first reagent for uric acid measurement of the present invention has not developed color even after 30 days of storage.
【0092】このことにより、本発明の化合物を色原体
として用いた、本発明の測定試薬では、アジ化ナトリウ
ム含有試薬から気化したアジ化物が本発明の測定試薬に
溶け込んでも試薬の劣化、機能の低下を防ぐことが出来
ることが確かめられた。Thus, in the measuring reagent of the present invention using the compound of the present invention as a chromogen, even if the azide vaporized from the sodium azide-containing reagent dissolves in the measuring reagent of the present invention, the deterioration and the function of the reagent are prevented. It has been confirmed that the decrease of the temperature can be prevented.
【0093】[0093]
【発明の効果】本発明の、前記の化学式(1)で表わさ
れる3−アルコキシアニリン誘導体又はその塩を色原体
として使用し、カップラーと組み合わせて用いた測定方
法及び測定試薬では、生成する色素の呈色は極めて安定
である。また、生体試料中にビリルビン、ヘモグロビ
ン、及びアスコルビン酸等の共存物質が含まれることに
より生じる測定値への誤差の発生を抑制することがで
き、更に、アジ化物等の近傍の試薬に含まれる成分が試
薬に溶け込むことによる試薬の劣化及び機能の低下を防
ぐことができ、これにより酸化性物質又はペルオキシダ
ーゼ様物質を正確に測定することができるという効果を
有するものである。According to the present invention, the 3-alkoxyaniline derivative represented by the above-mentioned chemical formula (1) or a salt thereof is used as a chromogen and the measuring method and the measuring reagent used in combination with a coupler produce a dye. Is extremely stable. In addition, it is possible to suppress the occurrence of an error in the measured value caused by the coexisting substance such as bilirubin, hemoglobin, and ascorbic acid in the biological sample, and furthermore, the component contained in a reagent such as azide or the like in the vicinity. Can be prevented from deteriorating and reducing the function of the reagent due to dissolution in the reagent, whereby the oxidizing substance or the peroxidase-like substance can be accurately measured.
【図1】安定性検討のための試薬の保存方法を示した図
面。FIG. 1 is a drawing showing a method of storing reagents for studying stability.
───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 2G054 AA06 AA07 AB02 CA10 CA26 CA28 CE01 EA04 EB02 JA11 4B063 QA01 QA19 QQ02 QQ03 QQ08 QQ09 QQ22 QQ65 QQ76 QQ79 QQ89 QR41 QR66 QS02 QX01 4H006 AA01 AA03 AB20 AB80 BJ50 BP30 BS10 BU46 ──────────────────────────────────────────────────続 き Continuing on the front page F term (reference) 2G054 AA06 AA07 AB02 CA10 CA26 CA28 CE01 EA04 EB02 JA11 4B063 QA01 QA19 QQ02 QQ03 QQ08 QQ09 QQ22 QQ65 QQ76 QQ79 QQ89 QR41 QR66 QS02 QX01 4H006 AA01 AB30 AB10 AB03 AB
Claims (7)
2は水素原子、又は炭素数1〜3のアルキル基を示し、
R3はカルボキシル基で置換された炭素数1〜3のアル
キル基を示す。)で示される、3−アルコキシアニリン
誘導体又はその塩。1. The following chemical formula (1): (Wherein, R 1 represents an alkoxy group having 1 to 3 carbon atoms;
2 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms,
R 3 represents an alkyl group having 1 to 3 carbon atoms substituted with a carboxyl group. A) 3-alkoxyaniline derivative or a salt thereof.
ン誘導体又はその塩よりなる色原体及びカップラーを被
酸化性発色試薬として用いることを特徴とする酸化性物
質の測定方法。2. A method for measuring an oxidizing substance, comprising using the chromogen and coupler comprising the 3-alkoxyaniline derivative or a salt thereof according to claim 1 as an oxidizable color-forming reagent.
ン誘導体又はその塩よりなる色原体及びカップラーを被
酸化性発色試薬として用いることを特徴とするペルオキ
シダーゼ様物質の測定方法。3. A method for measuring a peroxidase-like substance, comprising using the chromogen and coupler comprising the 3-alkoxyaniline derivative or a salt thereof according to claim 1 as an oxidizable color-forming reagent.
ある、請求項2又は3に記載の測定方法。4. The method according to claim 2, wherein the coupler is 4-aminoantipyrine.
ン誘導体又はその塩よりなる色原体及びカップラーを被
酸化性発色試薬として含有することを特徴とする酸化性
物質の測定試薬。5. A reagent for measuring an oxidizing substance, comprising a chromogen and a coupler comprising the 3-alkoxyaniline derivative or a salt thereof according to claim 1 as an oxidizable color developing reagent.
ン誘導体又はその塩よりなる色原体及びカップラーを被
酸化性発色試薬として含有することを特徴とするペルオ
キシダーゼ様物質の測定試薬。6. A reagent for measuring a peroxidase-like substance, comprising a chromogen and a coupler comprising the 3-alkoxyaniline derivative or a salt thereof according to claim 1 as an oxidizable color-forming reagent.
ある、請求項5又は6に記載の測定試薬。7. The measuring reagent according to claim 5, wherein the coupler is 4-aminoantipyrine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11161473A JP2000319238A (en) | 1999-04-30 | 1999-04-30 | Chromogen for oxidizable color-developing reagent, determination method using the chromogen and determination reagent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11161473A JP2000319238A (en) | 1999-04-30 | 1999-04-30 | Chromogen for oxidizable color-developing reagent, determination method using the chromogen and determination reagent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2000319238A true JP2000319238A (en) | 2000-11-21 |
Family
ID=15735770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11161473A Withdrawn JP2000319238A (en) | 1999-04-30 | 1999-04-30 | Chromogen for oxidizable color-developing reagent, determination method using the chromogen and determination reagent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000319238A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4300105A1 (en) * | 2022-06-29 | 2024-01-03 | ARKRAY, Inc. | Method for stabilizing hemoglobin |
-
1999
- 1999-04-30 JP JP11161473A patent/JP2000319238A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4300105A1 (en) * | 2022-06-29 | 2024-01-03 | ARKRAY, Inc. | Method for stabilizing hemoglobin |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0542272B2 (en) | ||
| JP5188111B2 (en) | Aniline derivative, and method, quantitative reagent, and quantitative kit for component to be quantified in sample using the same | |
| JPS61138163A (en) | Color developing coupler and use to measurement of hydrogen peroxide or other substance to be analyzed | |
| JP3569139B2 (en) | Diazonium ion assay reagent and method of use | |
| EP0488756B1 (en) | Oxidizable color producing reagent | |
| JP4073963B2 (en) | Ascorbic acid quantitative method and quantitative reagent | |
| JPS60180600A (en) | Determination of reduced-type nicotinamide adenine dinucleotide | |
| JP5631480B2 (en) | Method for the measurement of calcium ions | |
| JP5231392B2 (en) | Oxidative coloring compound or salt thereof, method for producing the same, reagent composition, and test device using the same | |
| JPH0532040B2 (en) | ||
| JP4640400B2 (en) | Component measurement reagent using catalase stabilizer | |
| JP2000319238A (en) | Chromogen for oxidizable color-developing reagent, determination method using the chromogen and determination reagent | |
| JP2008197077A (en) | Method and reagent for measuring object substance to be measured in sample, method for inhibiting nonspecific coloring, and nonspecific coloring inhibitor | |
| JP4122719B2 (en) | Catalase stabilizer | |
| JP3283348B2 (en) | Substance measurement method | |
| EP0160980B1 (en) | Novel method for determining cholinesterase activity | |
| JP5231063B2 (en) | Method for producing oxidation coloring compound | |
| EP0241915B1 (en) | Method for determining cholinesterase activity | |
| JPH01112155A (en) | Method for determination of hydrogen peroxide and reagent for said determination | |
| JPS6121546B2 (en) | ||
| JP3357667B2 (en) | Substance measurement method | |
| JPS58187858A (en) | Stabilization of oxidation-receiving color identification reagent | |
| JP2001352999A (en) | Oxidizing color reagent | |
| JPH0770462A (en) | Water-soluble methylenebisdialkylaniline derivative and its salts, and composition for quantifying peroxides using the same | |
| JPH0372619B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Application deemed to be withdrawn because no request for examination was validly filed |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20060704 |